Animal Outpatient Specialty Network Acquires a Portfolio of Outpatient Specialty Practices

Acquisition establishes the nation's largest dedicated outpatient veterinary specialty business and reinforces AOSN's position as the employer of choice for veterinary specialists

NEWPORT BEACH, Calif., Nov. 3, 2026 /PRNewswire/ -- Animal Outpatient Specialty Network ("AOSN"), a leading provider of outpatient veterinary specialty care, today announced the acquisition of a portfolio of outpatient specialty practices, including certain Arizona Veterinary Dental Specialists, Dentistry and Oral Surgery for Animals, Dermatology for Animals, Eye Care for Animals, and Veterinary Cancer Group clinics. The acquisition establishes AOSN as the nation's largest dedicated outpatient veterinary specialty business in the animal healthcare market, with over 300 veterinary specialists and residents nationwide. The acquisition brings together some of the most respected brands in veterinary specialty medicine with longstanding relationships with referring veterinarians and the communities they serve.

AOSN's specialistâled outpatient network spans dentistry and oral surgery, dermatology, internal medicine, oncology, ophthalmology, and surgery. Built by specialists, for specialists, the company invests significantly in training, continuing education, and technology solutions to help clinicians deliver exceptional patient care and outstanding service to pet parents and referring veterinarians. That commitment to specialist development extends to AOSN's residency program, the nation's largest in outpatient veterinary specialty medicine. Together, these investments have helped strengthen referral and client relationships and drive industry-leading organic growth.

"These are outstanding practices with talented teams, trusted brands, and deep roots in the communities they serve," said Steven Mrha, Chief Executive Officer of AOSN. "We have tremendous respect for what these practices have accomplished and are excited to welcome them to AOSN. Together, we have the opportunity to set a new standard for outpatient veterinary specialty care, where specialists can build exceptional careers, continue developing their skills, and deliver the highest quality care to their patients."

AOSN's growing network of highly regarded clinical teams, differentiated residency and professional development programs, and track record of strong specialist retention and organic growth position the company to expand access to highâquality outpatient veterinary specialty care nationwide.

About Animal Outpatient Specialty Network

Animal Outpatient Specialty Network (AOSN) is a national network of outpatient veterinary specialty practices spanning dentistry & oral surgery, dermatology, internal medicine, oncology, ophthalmology, and surgery. Built by specialists, for specialists, AOSN partners with leading specialists to deliver worldâclass outpatient specialty care in the communities where pet parents live and to train the next generation of veterinary specialists. For more information, please visit www.aosnetwork.com.

Media Contacts

Erik Carlson / Madeline Jones / Heather Milke

Joele Frank, Wilkinson Brimmer Katcher

212-355-4449

[email protected] 

SOURCE Animal Outpatient Specialty Network

Share this article

- Stable organic revenue1 development driven by growth in Care Delivery and Care Enablement, offset by the expected decline in profit-neutral Value-Based Care

- Operating income2 decreased by 6%, due to regulatory and inflation headwinds

- Reported operating income decreased by 19% and reported net income3 decreased by 42%, mainly due to one-time costs related to the China strategy refinement

- Earnings per share2 (EPS) remained stable supported by the share buyback program

- 348 U.S. clinics representing 16% of our U.S. dialysis machines converted to the 5008X CAREsystem⢠with 1.3 million treatments4

- FY 2026 outlook â revenue outlook broadly flat, operating income outlook narrowed to between flat and a negative mid-single digit percent growth rate

BAD HOMBURG, Germany, Nov. 3, 2026 /PRNewswire/ -- "Three weeks into my role as CEO, I am energized by the opportunities ahead. As a global leader in kidney care, Fresenius Medical Care combines exceptional capabilities with unparalleled reach. Following the structural changes of recent years, many parts of our business are still at an early stage of development. This creates a compelling opportunity to deliver transformational improvements in performance, not simply the incremental gains typically associated with more mature businesses. We are muted in our assessment of performance and endeavor to improve the current trajectory over time," said Shervin J. Korangy, new Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care. "With the FME25+ transformation, the company has built a solid foundation to continue to profitably grow and create value for all stakeholders. My focus will be on identifying opportunities to accelerate innovation, expand access to care, improve outcomes and drive long-term profitable growth."

Martin Fischer, Chief Financial Officer of Fresenius Medical Care outlined, "Fresenius Medical Care delivered a quarter of broadly stable revenue and resilient earnings development, as continued underlying performance improvements counter the expected negative effects from TDAPA regulations and increased inflation headwinds. Care Delivery further increased operating income2, driven by continued underlying operating income2 improvement of 21% excluding the negative TDAPA effects. The U.S. rollout of our innovative 5008X CAREsystem is progressing on plan, now available in 348 U.S. clinics, having performed 1.3 million treatments. The ongoing experience with the HvHDF modality in our clinics is exciting and clinical observations are consistently tracking very well compared with real-world data outside the U.S., which show to significantly improve patient outcomes."

Shervin J. Korangy concluded, "Based on the operating income development in the first nine months and the anticipated headwinds in the fourth quarter we narrowed our outlook for 2026 to the lower half of our outlook range."

Strategic progress

Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, continues to focus on execution to improve core operations and to drive profitable growth.

The large-scale U.S. commercial rollout of the innovative 5008X CAREsystem is progressing as planned. Since its launch in early 2026, approximately 16% of dialysis machines in Fresenius Medical Care's U.S. clinics have been replaced, keeping the company on track to reach its full-year target of around 20%. As adoption expands, treatments performed with the system have risen to 1.3 million, including more than 500,000 HDF treatments and more than 300,000 HvHDF treatments. Early observations are directionally better than previously published real-world data associating HvHDF with fewer hospitalizations, fewer missed treatments, and improved survival compared with conventional hemodialysis. At ASN Kidney Week in Denver, Colorado, we presented updates demonstrating the ability to achieve HvHDF for U.S. patients, with typical treatment times, blood and dialysate flows during therapy and look forward to presenting data in publications and congresses specifically around patient experience, hospitalizations, and survival through 2027.

In October, Fresenius Medical Care launched the multiFiltratePRO⢠system in the U.S. for critically ill patients with acute kidney injury (AKI). The system continuously cleans the blood, removing waste and extra fluid when a patient's kidneys can no longer do this on their own. multiFiltratePRO is the first FDA-cleared continuous kidney replacement therapy (CKRT) system in the U.S. for regional citrate anticoagulation using the Ci-Ca Protocol. The system brings important treatment steps together in one place, helping make a complex therapy easier for healthcare professionals to manage so they can focus on patient care.

The launch followed FDA clearance of multiFiltratePRO and approval of Cienbyâ¢, a sodium citrate solution, and Calrezdyâ¢, a calcium chloride solution. Together, these advances reflect Fresenius Medical Care's longstanding experience in developing and bringing complex kidney therapies to patients around the world.

In China, the company refined its commercial strategy by discontinuing production and sales of the 4008A hemodialysis system locally and exited its peritoneal dialysis (PD) business while maintaining existing obligations in the market. The resulting one-time costs of EUR 108 million are primarily attributable to impairment charges, scrappage and termination costs, treated as a special item in Care Enablement.

During the third quarter of 2026, the FME25+ transformation program delivered EUR 74 million additional sustainable savings while related one-time costs, treated as special items amounted to EUR 54 million. The company expects EUR 250 million savings and EUR 350 million related one-time costs in 2026. FME25+ savings are expected to total EUR 1.2 billion by the end of 2027.

As part of the capital allocation framework, share buyback programs complement shareholder returns through dividends. On May 26, a second program for a total volume of around EUR 1 billion (excluding ancillary costs) was announced and is being executed in tranches within 12 months. The first tranche was initiated on May 28 and is planned to end by December 15, 2026. As of September 30, 9.1 million shares or 3.4% of total shares issued have been repurchased for a total investment of EUR 357 million.

Organic revenue growth in Care Delivery and Care Enablement

In the third quarter of 2026, Group revenue increased by 1% compared to prior year (-1% at constant currency, +0.1% organic1) to EUR 4,937 million. Divestitures realized as part of the portfolio optimization plan negatively affected the revenue development by 30 basis points.

Care Delivery revenue increased by 3% (+1% at constant currency, +2% organic1) to EUR 3,492 million. Divestitures realized as part of the portfolio optimization plan negatively affected the revenue development by 40 basis points.

In Care Delivery U.S., revenue increased by 3% (+1% at constant currency, +1% organic1) to EUR 2,920 million. Favorable rate effects were offset by the TDAPA reimbursement regulations headwind as expected. U.S. same market treatment growth came in at -1.1%.

In Care Delivery International, revenue increased by 2% (+3% at constant currency, +6% organic1) to EUR 572 million, driven by positive organic growth1. International same market treatment growth amounted to 1.4%.

Value-Based Care revenue declined by 7% (-9% at constant currency, -9% organic1) to EUR 537 million. The development in the quarter was driven by the changed risk contracting for one of the contracts, partially offset by positive effects from payor premium rates and prior-year phasing of CKCC reporting from CMS.

Care Enablement revenue increased by 7% (+5% at constant currency, +5% organic1) to EUR 1,451 million. Positive pricing globally and positive volume development outside China were mainly driven by the sales of 5008X CAREsystem.

Within Inter-segment eliminations5, revenue for services provided and products transferred between the operating segments at fair market value came in at negative EUR 543 million.

In the first nine months of 2026, Group revenue decreased by 1% (+2% at constant currency, +3% organic¹) to EUR 14,409 million. Currency effects negatively impacted revenue development in all three operating segments. Divestitures realized as part of the portfolio optimization plan negatively impacted the revenue development by 40 basis points. Care Delivery revenue remained flat (+4% at constant currency, +5% organic1) at EUR 10,264 million, with Care Delivery U.S. flat (+4% at constant currency, +5 organic1) at EUR 8,582 million and Care Delivery International flat (+2% at constant currency, +7% organic1) at EUR 1,682 million. Divestitures realized as part of the portfolio optimization plan negatively affected the revenue development of Care Delivery by 70 basis points and the revenue development of Care Delivery International by 3,900 basis points. U.S. same market treatment growth came in at -0.8% while international same market treatment growth amounted to 1.2%. Value-Based Care revenue decreased by 3% (+1% at constant currency, +1% organic1) to EUR 1,563 million. Care Enablement revenue increased by 1% (+3% at constant currency, +3% organic1) to EUR 4,121 million. Inter-segment eliminations came in at negative EUR 1,539 million.

Earnings development in line with planned full-year phasing

In the third quarter of 2026, Group operating income declined by 19% (-19% at constant currency) to EUR 384 million, resulting in a margin of 7.8% (Q3 2025: 9.8%). Operating income excluding special items declined by 5% (-6% at constant currency) to EUR 545 million, resulting in a margin2 of 11.0% (Q3 2025: 11.7%).

Operating income in Care Delivery increased by 18% (+17% at constant currency) to EUR 497 million, resulting in a margin of 14.2% (Q3 2025: 12.3%).

Presentation to highlight the initial safety profile and antitumor activity of PT0253 in advanced solid tumors, including in patients who received prior (K)RAS-targeted therapy

BURLINGTON, Mass., Nov. 3, 2026 /PRNewswire/ -- PAQ Therapeutics, a clinical-stage biotechnology company developing targeted protein degraders for KRAS-driven cancers with significant unmet medical need, today announced that first clinical data for PT0253, its selective KRAS G12D degrader, will be presented in a late-breaking oral presentation at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026), being held November 18â20 in Barcelona, Spain. The presentation will report findings from the company's ongoing Phase 1 trial in patients with advanced solid tumors. PAQ will also present a poster describing the preclinical profile of PT0253.

ENA 2026 Presentations

Late-Breaking Oral Presentation

Abstract 6LBA: PT0253, a selective KRAS G12D degrader, shows a differentiated safety profile and antitumor activity, including after prior (K)RAS therapy, in advanced solid tumors

Session: Plenary Session 6 â Proffered Papers: Advances in Targeting RAS

Date/Time: Friday, November 20, 2026, 12:36â12:44 p.m. CET

Authors: Leontios Pappas, William B. McKean, Alexander I. Spira (Presenting Author), Drew W. Rasco, Ildefonso I. Rodriguez-Rivera, Anthony Tolcher, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Joon Oh Park, Heung-Moon Chang, Hong Jae Chon, Huaixiang Hao, Lokesh Gakhar, Joseph Donahue, Adam Shilling, Eric Rubin, Nan Ji, Andrew P. Krivoshik

Poster Presentation

Abstract 320: PT0253 is a potent and selective KRAS G12D degrader for treatment of cancers

Session: New Drugs

Date: Friday, November 20, 2026

Poster Board: PB-112

Authors: Huaixiang Hao, Pengrong Yan, Yuxin Wang, Fei Feng, Lokesh Gakhar, Ning Yin, Hui Qiu, Ruoxi Lan, Nan Ji

About PAQ Therapeutics

PAQ Therapeutics is a clinical-stage biotechnology company focused on advancing targeted protein degradation to address the unmet medical needs of patients with KRAS-driven cancers. Its clinical pipeline comprises PT0253, a selective KRAS G12D degrader, and PT0511, a pan-KRAS degrader, both in Phase 1 development for patients with advanced solid tumors. The company is based in Burlington, Massachusetts.

SOURCE PAQ Therapeutics

Share this article

Back-to-back recognition underscores high-quality guest experience consistently offered at alliance's first branded lounge

DALLAS and FORT WORTH, Texas, Nov. 3, 2026 /PRNewswire/ -- The oneworld® alliance's branded lounge at Seoul Incheon International Airport has again been named "Asia's Leading Airline Lounge - Business Class" at the World Travel Awards, securing the title for a second consecutive year.

"Retaining this prestigious award for a second year straight is a testament to the consistently high-quality experience enjoyed by the 150,000 guests who visit oneworld's Seoul Incheon lounge every year," said Gerhard Girkinger, vice president Customer Experience & Airports at oneworld. "Recognition from global travellers reinforces our commitment to delivering a premium experience that puts thoughtful service and close attention to detail at its heart."

Established in 1993, the World Travel Awards celebrate excellence across the travel and hospitality sectors. Winners are selected through a voting process that includes travel professionals and travellers.

"This accolade is a credit to our team at Seoul Incheon and the care and attentiveness they show to oneworld lounge guests every day," said David Collyer, Global Senior Vice President of Aspire Pre-Flight Hospitality, which manages the operation of the lounge. "We're proud to support oneworld in delivering the highest quality pre-flight hospitality and an award-winning lounge experience for a second consecutive year."

Seoul Incheon is the first oneworld-branded lounge and opened in January 2024. The 555-square-metre lounge features seasonally rotating menus and design elements inspired by South Korea, including a bar influenced by the traditional 'Gat' hat and glass art evoking the Lantern Festival. Distinct zones offer a choice of settings in which to dine, work, recharge or relax before departure for eligible oneworld Emerald and Sapphire customers, as well as First and Business Class customers.

Seoul Incheon is served by seven oneworld member airlines: Alaska Airlines, American Airlines, Cathay Pacific, Finnair, Malaysia Airlines, Qatar Airways and SriLankan Airlines.

About Aspire Pre-Flight Hospitality

Aspire Pre-Flight Hospitality (Aspire) is one of the world's leading airport hospitality businesses. With over 35 years' airport hospitality experience, Aspire's vision is to translate the luxurious hotel experience into an exceptional lounge and lifestyle experience.

More than six million guests annually are welcomed to Aspire lounges. As of mid-2026, Aspire has 110 lounges open, or scheduled to open around the world and continues to invest in premium airport hospitality concepts across key markets. New openings in 2026, include lounges in Stockholm, Geneva, Marrakesh, Calgary, Manchester and Vilnius. Aspire's portfolio includes not only the flagship Aspire Lounges but also partnerships with major airline lounges, alliance lounges, bank and credit card lounges.

The award-winning company has notably achieved the Leadership in Energy and Environmental Design (LEED) certification for its lounge at Billy Bishop Toronto City Airport (YTZ), and was the only independent lounge operator recognised at the Cellar in the Sky Awards 2026.

Aspire is part of Swissport International AG, a leading provider of aviation services including airport ground services and air cargo handling.

For more information about Aspire visit: aspirelounges.com and connect with us on our social channels: Facebook and Instagram.

For further media information please contact:

Email: [email protected]

About oneworld

oneworld brings together 15 world-class airlines â Alaska Airlines/Hawaiian Airlines, American Airlines, British Airways, Cathay Pacific, Fiji Airways, Finnair, Iberia, Japan Airlines, Malaysia Airlines, Oman Air, Qantas, Qatar Airways, Royal Air Maroc, Royal Jordanian and SriLankan Airlines to nearly 1,000 destinations. oneworld member airlines work together to consistently deliver a superior, consistent travel experience, with special rewards and privileges for its frequent flyers, including earning and redeeming miles and points across the entire alliance network, access to airport lounges, priority check in and boarding and extra baggage allowances and more. Learn more about the oneworld Alliance at oneworld.com.

Follow us on Facebook, Instagram, X and LinkedIn.

For media enquiries: [email protected]

SOURCE oneworld Management Company, Inc

Share this article

CityUHK achieves a historic 4th place in QS Asia University Rankings 2027, debuts in Asia's top five; tops Asia in three indicators and Hong Kong in eight

HONG KONG, Nov. 3, 2026 /PRNewswire/ -- City University of Hong Kong (CityUHK) reached a historic milestone in the Quacquarelli Symonds (QS) Asia University Rankings 2027, rising to 4th place in Asia among 1,725 participating institutions and placing 2nd in Hong Kong. CityUHK entered Asia's top five for the first time, reflecting its steady progress and dedication to academic research, pedagogical excellence and internationalisation.

Hong Kong's higher education sector also achieved a significant milestone this year, with three universities placing among Asia's top five for the first time ever, further reinforcing the city's position as an international education hub. CityUHK rose three places from last year to rank 4th in Asia and 2nd in Hong Kong.

QS Asia University Rankings 2027: Hong Kong institutions

CityUHK excelled across major evaluation metrics, ranking 1st in Asia in three indicators and 1st in Hong Kong in eight indicators. The University achieved the top position in Asia for "Staff with PhD", "International Faculty" and "Outbound Exchange Students", demonstrating its leadership in academic talent, internationalisation and global mobility opportunities.

In scholarly research, CityUHK maintained its strong academic performance, ranking 1st in Hong Kong for "Staff with PhD", "Citations per Paper" and "Papers per Faculty". These accomplishments reflect the University's success in attracting outstanding researchers and generating high-impact research with global influence.

The University also maintained its leadership in internationalisation, ranking 1st in Hong Kong for the fourth consecutive year (2024-2027) across all four internationalisation indicators: "International Faculty", "International Students", "Inbound Exchange Students" and "Outbound Exchange Students". In addition, CityUHK ranked 1st locally in the "Faculty Student Ratio" indicator.

Furthermore, CityUHK recorded notable improvements in both the "Academic Reputation" and "Employer Reputation" indicators, reflecting growing recognition from the global academic community and employers for the University's research excellence, teaching quality and graduates' competitiveness.

Professor Chun-Sing Lee, Acting President of CityUHK, welcomed the announcement, stating, "CityUHK's rise to 4th in Asia, entering the top five for the first time, and ranking 2nd locally, is an encouraging achievement. This progress reflects the collective efforts of our academic community to pursue excellence in research and create an inspiring learning environment. It also demonstrates the success of our strategic commitment to recruiting global academic talent and nurturing future leaders."

"As a globally engaged institution rooted in Hong Kong, CityUHK will continue to advance interdisciplinary collaboration, broaden international scholarly exchange, and welcome outstanding students and scholars from around the world," added Professor Lee. "We remain committed to supporting the HKSAR Government's 'Study in Hong Kong' initiative, contributing to Hong Kong's development as an international education hub."

CityUHK also received two major QS honours: the "Research and Discovery Champions" award, which commends distinction in academic reputation, citation impact and publication output, and the "Learning Experience Champions" award, which recognises institutions that provide high-quality learning environments supported by favourable faculty-student ratios and highly qualified staff.

CityUHK's institutional progress is consistently reflected in other global benchmarks. Alongside being recognised by Times Higher Education (THE) as the Most International University in the World for three consecutive years, CityUHK is the second university in Hong Kong to achieve top-100 standing across all four major world university rankings: QS, THE, US News and ShanghaiRanking. Moving forward, CityUHK will continue to deepen research synergies with leading institutions worldwide, translating research findings into practical solutions for society.

Share this article

NextEra Energy and Dominion Energy strengthen historic Virginia benefits package with additional customer and financial safeguards

- Filed testimony reflects strong alignment with key conditions proposed by Commission Staff and the Office of the Attorney General Division of Consumer Counsel ensuring robust financial safeguards and independence for Dominion Energy Virginia.

- Preserves all elements of existing benefits package, including delivering immediate bill relief and long-term affordability through four years of shareholder-funded residential bill credits and continued access to NextEra Energy's capital, scale and proven ability to buy, build, finance and operate more efficiently.

- Positions Virginia to meet extraordinary growth in electricity demand while preserving Dominion Energy Virginia's local leadership and full accountability to the Virginia State Corporation Commission.

- Builds on NextEra Energy's proven record at Florida Power & Light Company, where typical residential bills are 37% below the national average and reliability is more than 60% better than the national average.

JUNO BEACH, Fla., Nov. 3, 2026 /PRNewswire/ -- NextEra Energy, Inc. (NYSE: NEE) and Dominion Energy, Inc. (NYSE: D) have filed rebuttal testimony with the Virginia State Corporation Commission strengthening their proposed combination with additional customer and financial protections.

The companies' testimony reflects strong alignment with key conditions proposed by the Virginia State Corporation Commission Staff and the Office of the Attorney General Division of Consumer Counsel (Consumer Counsel) ensuring robust financial safeguards and independence for Dominion Energy Virginia. Of the 117 conditions proposed by the Commission Staff and the Consumer Counsel, the companies have accepted 101 conditions as proposed and another 13 conditions with enhancements or modifications.

As a result, the companies have strengthened the enhanced package with additional financial and governance safeguards. These measures reinforce Dominion Energy Virginia's financial separation from affiliated businesses, add independent oversight, strengthen Virginia representation on its board and protect the utility's financial strength â all while preserving access to NextEra Energy's capital.

The companies remain confident the merger satisfies Virginia's legal standard that adequate service to the public at just and reasonable rates will not be impaired or jeopardized by the proposed transaction. In fact, the proposal exceeds the standard by proposing significant benefits in terms of customer affordability, jobs in our service area and development of needed energy resources, as well as in terms of strengthening the parent that would be backing Virginia's largest utility.

A word from John Ketchum, chairman and CEO of NextEra Energy

"We have already put forward a historic package of benefits for Dominion Energy Virginia customers, workers and communities, and we are going even further. Virginia should not have to choose between relief on electric bills today and affordable, reliable power tomorrow. Our proposal delivers four years of shareholder-funded bill credits for Dominion Energy Virginia customers while putting NextEra Energy's scale, financial strength and operating experience behind the local Dominion Energy team Virginians know and trust. We have listened carefully to stakeholders, and our filing accepts the vast majority of the additional protections proposed by Commission Staff and the Consumer Counsel while offering targeted alternatives to a limited number of remaining provisions. Together, these commitments strengthen protections for customers while preserving the financial and operating capabilities needed to build and finance Virginia's energy future more efficiently."

A word from Bob Blue, chair, president and CEO of Dominion Energy

"Dominion Energy has proudly served Virginia for more than a century. This combination is about building on that legacy. Dominion Energy Virginia would remain locally led and accountable to the State Corporation Commission, supported by NextEra Energy's financial strength and operational expertise. These additional protections reinforce our commitment to our customers as we continue to reliably and affordably meet Virginia's growing energy needs."

The companies' rebuttal testimony outlines additional commitments designed to address concerns raised by Commission Staff and the Consumer Counsel while preserving Dominion Energy Virginia's financial strength and ability to serve customers. For the limited number of provisions not accepted as proposed, the companies offered targeted alternatives designed to address the underlying concerns without unnecessarily increasing costs or restricting parent company capital or operational efficiencies that should benefit customers.

Protecting affordability while meeting Virginia's growing energy needs

The companies' proposal is designed to deliver both immediate bill relief and long-term affordability. Customers will not pay one cent for this combination. Four years of shareholder-funded residential bill credits and an additional $100 million for EnergyShare would provide near-term assistance, while the combined company's ability to buy, build, finance and operate more efficiently would help manage customer costs as Virginia's energy needs continue to grow.

Virginia's extraordinary growth in electricity demand will require significant investments in new generation, transmission and grid infrastructure, regardless of whether the proposed combination moves forward. Dominion Energy Virginia would be better positioned to meet those challenges with NextEra Energy's financial strength, scale and proven operating capabilities, helping to manage costs for customers over the long term.

NextEra Energy's track record at its Florida utility, Florida Power & Light Company (FPL), demonstrates how those capabilities benefit customers. FPL's typical residential bills are 37% below the national average and 20% lower than two decades ago in inflation-adjusted dollars, while its reliability is more than 60% better than the national average.

A generational investment in Virginia

The proposed combination includes commitments to:

- Provide four years of shareholder-funded bill credits.

- Contribute $100 million for EnergyShare for energy assistance and weatherization.

- Invest $100 million for workforce development and skilled-trades training.

- Create 1,000 new jobs, including 600 NextEra Energy jobs and approximately 400 jobs with suppliers, contractors and service providers.

- Maintain Dominion Energy's current Virginia employee headcount for at least five years.

- Build a new shareholder-funded office tower in downtown Richmond and maintain dual headquarters.

- Spend up to $5 billion over five years with Virginia-based manufacturers, contractors, suppliers and service providers through a new Virginia Supplier Program.

Together, these commitments would provide immediate customer relief, support long-term affordability and create significant economic opportunities across the Commonwealthâall while preserving Dominion Energy Virginia's local leadership, separate regulation and full accountability to the State Corporation Commission.

The proposed combination remains subject to required regulatory approvals and other customary closing conditions. The companies continue to expect the transaction to close in the second half of 2027.

Additional information about the proposed combination, including the filing, is available at DominionNextEraFuture.com.

About NextEra Energy

NextEra Energy, Inc. (NYSE: NEE) is the largest electric power and energy infrastructure company in North America and is a leading provider of electricity to American homes and businesses. Headquartered in Juno Beach, Florida, NextEra Energy is a Fortune 200 company that owns Florida Power & Light Company, America's largest electric utility, which provides reliable electricity to approximately 12 million people across Florida. NextEra Energy also owns the largest energy infrastructure development company in the U.S., NextEra Energy Resources, LLC. NextEra Energy and its affiliated entities are meeting America's growing energy needs with a diverse mix of energy sources, including natural gas, nuclear, renewable energy and battery storage. For more information about NextEra Energy companies, visit these websites: www.NextEraEnergy.com, www.FPL.com, www.NextEraEnergyResources.com.

About Dominion Energy

Dominion Energy (NYSE: D), headquartered in Richmond, Va., provides regulated electricity service to 3.6 million homes and businesses in Virginia, North Carolina, and South Carolina, and regulated natural gas service to 500,000 customers in South Carolina. The company is one of the nation's leading developers and operators of regulated offshore wind and solar power and the largest producer of carbon-free electricity in New England. The company's mission is to provide the reliable, affordable, and increasingly clean energy that powers its customers every day. Please visit DominionEnergy.com to learn more.

Forward-Looking Statements

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included or incorporated by reference in this news release, including, among other things, statements regarding the proposed business combination transaction between NextEra Energy, Inc. (NextEra Energy) and Dominion Energy, Inc.

CHANGZHOU, China, Nov. 3, 2026 /PRNewswire/ -- STAK Inc. (the "Company") (Nasdaq: STAK), a fast-growing company specializing in the research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment, today announced the appointment of Mr. Xiaofei Han as the Chief Financial Officer of the Company, effective November 1, 2026.

Mr. Han has approximately 20 years of experience in accounting, auditing, financial management and capital markets. Prior to joining the Company, he served as a Senior Auditor at the Guangzhou Branch of Deloitte Touche Tohmatsu Certified Public Accountants LLP from July 2007 to January 2011. He subsequently joined Marcum Bernstein & Pinchuk LLP from February 2011 to June 2017, where he served as an Audit Manager and Senior Manager, with responsibility for providing audit services to U.S.-listed companies and IPO audit services to companies preparing to go public. Since then, Mr. Han has provided financial advisory services to Chinese companies seeking listings in the U.S. capital markets. He founded Guangzhou Jingtian Enterprise Consulting Co., Ltd. in August 2019. Mr. Han received a Bachelor of Management from Sun Yat-sen University and is a member of Chinese Institute of Certified Public Accountants (CICPA).

The Company also announced the resignation of Ms. Diana Li as the Chief Financial Officer of the Company, effective October 31, 2026. The Company further announced the resignation of Mr. Ke Dennis Xu as the Chief Technology Officer of the Company, effective October 31, 2026. The resignations were not result of any disagreement with the Company.

About STAK Inc.

STAK Inc. is a fast-growing company specializing in the research, development, manufacturing, and sale of oilfield-specific production and maintenance equipment. The Company designs and manufactures oilfield-specialized production and maintenance equipment, then collaborates with qualified specialized vehicle manufacturing companies to integrate the equipment onto vehicle chassis, producing specialized oilfield vehicles for sale. Additionally, the Company sells oilfield-specialized equipment components, related products, and provides automation solutions. Its vision is to help oilfield services companies reduce costs and increase efficiency by providing the cutting-edge integrated oilfield equipment and automation solutions service. Its mission is to become a powerful provider for the niche markets of specialized oilfield vehicles and equipment in China. For more information, please visit the Company's website at https://www.stakindustry.com/ir/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as "may," "will," "expect," "anticipate," "aim," "estimate," "potential," "intend," "plan," "believe," "likely to" or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission (the "Commission").

For more information, please contact:

STAK Inc.

Investor Relations Department

Email: [email protected]

Ascent Investor Relations LLC

Tina Xiao

Phone: +1-646-932-7242

Email: [email protected]

SOURCE STAK Inc.

Share this article

MILWAUKEE, Nov. 3, 2026 /PRNewswire/ -- Regal Rexnord Corporation (NYSE: RRX)

3Q Highlights

- Daily Orders Up 6% Versus PY

- Sales Of $1,588 Million, Up 6% Versus PY

- Data Center Sales Up 307%, Or Up 169% Excluding E-Pods  

- GAAP Net Loss Of $12 Million* Versus PY GAAP Net Income Of $80 Million

- Adjusted EBITDA Of $351 Million Versus PY Of $339 Million, Up $12 Million, Or 4%, Versus PY

- Adjusted EBITDA Of $337 Million Excluding IEEPA Tariff Refunds, Ahead Of Expectations

- Net Debt To Adjusted EBITDA (Including Synergies) Ended 3Q At 2.9x

CEO Aamir Paul commented on the third quarter performance, "Our third quarter execution showed steady progress. We delivered adjusted EBITDA excluding IEEPA refunds slightly ahead of our expectations. We had healthy order demand across the portfolio, with 13% orders growth excluding data centers. We were encouraged by the orders growth in commercial HVAC, up 47%, aided by new air moving solutions. Discrete automation orders were up 26%. Data center order growth continues to scale, with some specific project order timing effects in the quarter."

Providing a strategic update, Paul continued, "Four months into the role, I see opportunities to accelerate profitable growth. These encompass improving operational performance, sharpening the focus of our growth agenda, and building a stronger growth mindset in our team. To improve focus and maximize value creation at the enterprise level, we have begun a comprehensive review of our portfolio, working closely with our Board and with the support of outside advisors. Ultimately the goal is directing capital to our most attractive opportunities. While this work is ongoing, we are committed to moving with urgency when we see opportunity. Today's announcement that we are exploring the sale of our autonomous mobile solutions business in the AMC segment reflects this approach. We plan to share further updates when we have something definitive to share."

Paul concluded, "There is significant work ahead, but we have a strong foundation and clear opportunities to build upon. I am confident in our ability to deliver on that potential and excited about what lies ahead."

Guidance Update

We are lowering and narrowing our 2026 GAAP EPS guidance to a range of $3.76 to $4.06*. We are raising and narrowing our 2026 Adjusted Diluted EPS guidance range to $10.60 to $10.90. Our Adjusted Diluted EPS guidance range mid-point rises to $10.75.

Segment Performance

Segment results for the third quarter of 2026 versus the same period of the prior year are summarized below:

- Automation & Motion Control (AMC) net sales were $500.6 million, an increase of 24.5%, or an increase of 25.2% on an organic basis. Growth was broad-based, but with particular strength in data center, including $25 million of sales related to E-Pods, and in discrete automation. Adjusted EBITDA margin was 19.2% of net sales or 18.7% excluding net IEEPA refund benefits.

- Industrial Powertrain Solutions (IPS) net sales were $649.5 million, a decrease of 1.9%, or a decrease of 1.8% on an organic basis driven by weakness in metals and mining partially offset by strength in discrete automation and energy markets. Adjusted EBITDA margin was 26.0% of net sales or 25.2% excluding net IEEPA refund benefits.

- Power Efficiency Solutions (PES) net sales were $437.9 million, an increase of 1.2%, or an increase of 0.4% on an organic basis. Growth in the commercial HVAC market was partially offset by weakness in the residential HVAC and pool markets. Adjusted EBITDA margin was 19.7% of net sales, or 18.1% excluding net IEEPA refund benefits.

Conference Call

Regal Rexnord will hold a conference call to discuss this earnings release at 9:00 AM CT (10:00 AM ET) on Tuesday, November 3, 2026. To listen to the live audio and view the presentation during the call, please visit Regal Rexnord's Investor website: https://investors.regalrexnord.com. To listen by phone or to ask the presenters a question, dial 1-877-264-6786 (U.S. callers) or 1-412-317-5177 (international callers) and enter 7570153# when prompted. Participants on the call will include Aamir Paul, CEO, and Rob Rehard, EVP & CFO.

A webcast replay will be available at the link above, and a telephone replay will be available at 1-855-669-9658 (U.S. callers) or 1-412-317-0088 (international callers), using a replay access code of 9141496#. Both replays will be accessible for three months after the earnings call.

Supplemental Materials

Supplemental materials and additional information for the quarter ended September 30, 2026 will be accessible before the conference call on November 3, 2026 on Regal Rexnord's Investor website: https://investors.regalrexnord.com. The Company intends to disseminate important information about the Company to its investors on the Investors section of its website: https://investors.regalrexnord.com. Investors are advised to look at Regal Rexnord's website for future important information about the Company. The content of the Company's website is not incorporated by reference into this document or any other report or document Regal Rexnord files with the Securities and Exchange Commission.

About Regal Rexnord

Regal Rexnord's 30,000 associates around the world help create a better tomorrow by providing sustainable solutions that power, transmit and control motion. The Company's electric motors and air moving subsystems provide the power to create motion. A portfolio of highly engineered power transmission components and subsystems efficiently transmits motion to power industrial applications. The Company's automation offering, comprised of controllers, drives, precision motors, and actuators, controls motion in applications ranging from factory automation to precision tools used in surgical applications.

The Company's end markets benefit from meaningful secular demand tailwinds, and include discrete automation, food & beverage, aerospace & defense, medical, data center, energy, residential and commercial buildings, general industrial, and metals and mining.

Regal Rexnord is comprised of three operating segments: Automation & Motion Control, Industrial Powertrain Solutions, and Power Efficiency Solutions. Regal Rexnord is headquartered in Milwaukee, Wisconsin and has manufacturing, sales and service facilities worldwide. For more information, including a copy of our Sustainability Report, visit RegalRexnord.com.

Forward Looking Statements

All statements in this communication, other than those relating to historical facts, are "forward-looking statements." Forward-looking statements can generally be identified by their use of terms such as "anticipate," "believe," "confident," "estimate," "expect," "intend," "plan," "may," "will," "project," "forecast," "would," "could," "should," and similar expressions, including references to assumptions. Forward-looking statements are not guarantees of future performance and are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such statements. Forward-looking statements include, but are not limited to, statements about expected market or macroeconomic trends, future strategic plans, and future financial and operating results. Important factors that could cause actual results to differ materially from those presented or implied in the forward-looking statements in this communication include, without limitation: the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the sale of the Industrial Motors and Generators businesses in 2024 and the acquisition of Altra Industrial Motion Corp. in 2023 ("Altra Transaction") within the expected time-frames or at all and to successfully integrate Altra Industrial Motion Corp.

- Health Canada Medical Device License makes VitaSmart® available to transplant centers across Canada

- U.S. FDA grants Breakthrough Device Designation for the use of the VitaSmart® System for investigational hypothermic oxygenated perfusion of donor intestines

DULUTH, Ga., Nov. 3, 2026 /PRNewswire/ -- Bridge to Life⢠Ltd., a global innovator in organ preservation solutions and perfusion technologies, today announced two regulatory milestones that expand the company's addressable market and build momentum for its VitaSmart® platform. Health Canada has issued a Medical Device License for the VitaSmart® Hypothermic Oxygenated Perfusion (HOPE) System for hypothermic oxygenated perfusion of donor livers, making the system available to transplant centers across Canada, while the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the system's investigational use in hypothermic oxygenated perfusion of donor intestines.

More than 4,000 Canadians and over 100,000 Americans are currently on waiting lists to receive life-saving organ transplants, and the shortage of transplantable organs remains one of the greatest constraints in transplant care. VitaSmart® is designed to help transplant teams address this gap by mitigating ischemic injury and supporting confident use of more donor livers. In the U.S. Bridge to HOPE randomized controlled trial, conducted across 15 transplant centers with 219 recipients, VitaSmart® HOPE improved early allograft function in liver transplantation. These milestones strengthen Bridge to Life's position as it converts pipeline innovation into commercial opportunities with scalable adoption.

"Securing our Canadian market authorization alongside FDA Breakthrough Device Designation continues to accelerate momentum in our global commercial trajectory," said Don Webber, President and Chief Executive Officer of Bridge to Lifeâ¢. "Our vision has always focused on removing friction points within the transplant care ecosystem. VitaSmart® is engineered to be portable, operationally versatile, and seamless to embed into standard clinical workflows. By giving surgical teams better preservation options, we aim to help them use more of the organs available to them, improve outcomes for recipients, and save more lives."

Opportunity to save more lives with Canadian authorization

With Health Canada authorization secured, the company is set to introduce VitaSmart® to liver transplant surgeons and care teams across Canada. This achievement underscores a commitment to working alongside North American healthcare professionals to deliver technologies tailored to modern transplantation needs, advancing organ preservation standards and improving outcomes for transplant recipients. As part of this Canadian market launch, Bridge to Life⢠leaders attended the Canadian Society of Transplantation (CST) Annual Scientific Meeting in Montreal, QC, in October.

FDA Breakthrough Device Designation in the U.S.

Following the FDA's January 2026 De Novo clearance of the VitaSmart® System for hypothermic oxygenated perfusion of donor livers after static cold storage, within defined DBD and DCD donor criteria, the FDA has now granted Breakthrough Device Designation for the system's investigational use in the hypothermic oxygenated perfusion of donor intestines. The Breakthrough Devices Program is intended to provide more timely FDA interaction and prioritized review for devices that may offer more effective treatment of life-threatening or irreversibly debilitating conditions. Breakthrough Device Designation does not constitute FDA clearance or approval, and the intestinal application remains investigational.

The designation is a meaningful milestone for the platform in intestinal transplantation, a field with significant unmet need given the intestine's sensitivity to ischemic injury. It also builds upon Bridge to Life's broader strategy to establish VitaSmart® as a versatile, multi-organ platform. Beyond North America, VitaSmart® is already used for both liver and kidney preservation in Europe. It is also available in Saudi Arabia, India, and in all countries accepting the CE mark.

Bridge to Life⢠is also supporting active investigator studies evaluating the system's efficacy in pancreas preservation. VitaSmart® was recently highlighted in Sydney during the 31st International Congress of The Transplantation Society, which featured presentations on successful pediatric multivisceral transplant cases involving all abdominal organs.

About Bridge to Life⢠Ltd.

Bridge to Life⢠Ltd. is a global innovator in organ preservation and perfusion technology. Driven by a commitment to science-based innovation, the company empowers transplant teams with advanced tools that help expand the donor pool, streamline clinical workflows, and improve patient outcomes worldwide. VitaSmart® joins a preservation franchise anchored by Belzer UW®, one of the most widely used preservation solutions in abdominal organ transplantation. Together, the portfolio gives Bridge to Life⢠a differentiated position spanning both established preservation and next-generation machine perfusion.

Product Development Statement

Pipeline programs described in this release, including applications for intestinal perfusion, are investigational, and are not cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority. Nothing herein should be construed as a claim of safety or effectiveness for any use that has not received clearance or approval.

SOURCE Bridge to Life, Ltd.

Share this article

Latest RECMA Diagnostics Report sees OM agency OMD scoring its 12th consecutive #1 ranking, with PHD and Initiative ranked in the top five

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- In the latest edition of the Network Diagnostics report from RECMA (Research Company Evaluating the Media Agency Industry), Omnicom Media, an Omnicom (NYSE: OMC) Connected Capability, has again been named the best performing global media group, topping both the global ranking as well as the regional rankings across North America, EMEA, APAC and LATAM. This marks the second consecutive report in which Omnicom Media has topped the Network Diagnostics report's global and regional rankings.

As RECMA notes in its report, Omnicom Media "is emerging as the new industry powerhouse." The leader in Activity Volume/Billings with approximately 30% industry share, Omnicom Media also leads this Diagnostic Report with just under 35% of quali-share.

Widely considered the most comprehensive report for analyzing media agency performance, the bi-annual RECMA Diagnostics report is based on the evaluation of approximately 700 agencies in 45 markets. Utilizing 19 KPIs to evaluate vitality and structure, the report offers an assessment index that goes beyond typical quantitative metrics such as new business wins or billings volume alone to also consider criteria such as client portfolio and relationship stability; digital, data & content resources; and homogeneity across geographies. Participating agencies are ranked both numerically by "quali-points" and by the following profiles: Dominant, High Profile, Very Good Profile, Good Profile, and Average Profile.

The Dominant profile is awarded in a market where an agency significantly outperforms its competitors across multiple Diagnostic criteria. In the current report, Omnicom Media agency brands were dominant in 19 markets - more than any other media group â encompassing all four regions.

"These results are a powerful validation that our Growth by Design strategy - built on the simple premise of bringing together our singular advantages in scale, data, identity, commerce, and talent to create a competitive advantage for our clients â is working," says Omnicom Media CEO Florian Adamski. "Leading RECMA's global and all four regional rankings for the second consecutive time since the integration of Omnicom and IPG's media groups, and with three agencies among the global top five, demonstrates the strength of our connected capabilities and our ability to consistent translate them into outsize growth for the world's leading brands."

The RECMA ranking lands amidst a winning streak for Omnicom Media, which in October alone won the media business for The Coca-Cola Company in North America; grocery retailer Lidl across Europe; the global assignment for Lavazza coffee; The British Council; and the L'Oréal business in the DACH region. Adding this 30-day sprint to a 2026 global and regional win record that already included Adidas, Aviva, CVS, Delta, Dyson, IBM, Novo Nordisk, Uber, and Xiaomi brings Omnicom Media's YTD total to approximately US$10 billion in billings won or retained through competitive pitches, more than any other holding company.

Omnicom Media Agencies Dominant the Top Five

Three Omnicom Media agencies - OMD, PHD and Initiative - were among the top five best performing global media agencies, with OMD topping the ranking for the 12th consecutive report.

OMD also stood out as the most balanced agency in terms of performance across the 45 countries studied, ranked as Dominant or High Profile in 29 markets (65% of those evaluated); and was ranked #1 globally for both Digiday Data & Content Experts and its Client Portfolio Profile, which shows very good relationship stability across a roster that includes both major international accounts and a strong local client base.

Hearts United - OM's newly launched agency that brought together Hearts & Science and Mediahub â and PHD were both among the agencies that showed the greatest increase in quali-share scores since the last report as well as over a three-year window, with Hearts United topping this ranking and PHD close behind at #3.

Noting the positive impact that Omnicom's acquisition of IPG has had on the OM agency portfolio, RECMA notes, "all of the group's agencies are benefiting from the advantages in this evaluation, particularly the integration of data and digital specialist units."

Says Adamski, "RECMA's findings underscore the value of what we are building together. The integration of our data and digital specialists, combined with the depth of talent and expertise across our agency portfolio, is creating capabilities that are greater than the sum of their parts. We have the scale to shape the marketplace, the intelligence to make better decisions and the talent to turn those advantages into results. That positions Omnicom Media not simply to lead today's industry, but to help define what the next generation of media looks like."

"Ultimately, the value of our combined capabilities is measured by what they make possible for our clients," says Adamski. By connecting data, identity, commerce, technology, and talent across our business, we can give clients a more complete view of their opportunities, make better investment decisions and turn those decisions into stronger business outcomes. The advantage is not simply the scale of what we bring together, but how we put it to work to help our clients grow, compete, and stay ahead in an increasingly complex marketplace."

CONTACT: [email protected]

ABOUT OMNICOM MEDIA

Omnicom Media, an Omnicom (NYSE: OMC) Connected Capability, is the world's largest global media management network. Powered by the Omni Intelligence Platform, Omnicom Media agencies leverage $75.6 billion in billings, 47,000 specialists across 70+ markets, and the industry's most powerful portfolio identity, commerce, and intelligence assets to design dynamic Growth Ecosystems that enable the world's most ambitious businesses to grow faster and smarter. The Omnicom Media portfolio includes global media agency brands OMD, PHD, Initiative, Hearts United, and UM; core Omnicom Integrated Media offerings Acxiom, the world's premier identity solution, and the Flywheel end-to-end commerce solution; and specialty services across the cloud consulting, creator, financial, healthcare, and sports & entertainment categories. For more information visit omnicommedia.com

About RECMA

RECMA was founded in June 1991 in Paris and is the only global research company that evaluates and rates media agencies qualitatively and quantitatively. RECMA is the leading research company producing a wide range of rankings and reports dedicated to the media industry professionals. RECMA collects and analyzes data from more than 1000 media agencies in 70 countries. For more information visit recma.com.

SOURCE Omnicom Media

Share this article